SCHEMBL10143786

SCHEMBL10143786

CCCCOC[C@H]1OC(O)(c2ccc3c(N)ncnn23)[C@H](OCCCC)[C@@H]1OCCCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10142421 1.00 — —
SCHEMBL4970277 0.91 — —
SCHEMBL10142123 0.89 — —
SCHEMBL12454580 0.88 — —
SCHEMBL17130412 0.87 — —
SCHEMBL17131380 0.87 — —
SCHEMBL25822069 0.87 — —
SCHEMBL25822075 0.87 RIPK1 (0.30) —
SCHEMBL17722656 0.87 — —
SCHEMBL25822058 0.86 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240239830-A1 METHODS OF PREPARING CARBANUCLEOSIDES USING AMIDES ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD. (CN) 2024-07-18 — — US disclosed
US-20240025873-A1 METHOD FOR PRODUCING KETONE DERIVATIVE TOKUYAMA CORPORATION (JP) 2024-01-25 — — US disclosed
US-20230295214-A1 METHODS OF PREPARING 1`-CYANO NUCLEOSIDES GILEAD SCIENCES, INC. 2023-09-21 — — US disclosed
WO-2017184668-A1 METHODS FOR TREATING FLAVIVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. (US) 2017-10-26 — — WO disclosed
US-9724360-B2 Methods for treating Filoviridae virus infections GILEAD SCIENCES, INC. (US) 2017-08-08 — — US disclosed
WO-2017049060-A1 METHODS FOR TREATING ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. (US) 2017-03-23 — — WO disclosed
US-20170071964-A1 METHODS FOR TREATING ARENAVIRIDAE AND CORONAVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. 2017-03-16 — — US disclosed
US-20160361330-A1 METHODS FOR TREATING FILOVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. 2016-12-15 — — US disclosed
US-20160122374-A1 METHODS FOR TREATING FILOVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. 2016-05-05 — — US disclosed
US-20160122356-A1 METHODS FOR THE PREPARATION OF RIBOSIDES GILEAD SCIENCES, INC. 2016-05-05 — — US disclosed
US-20150152116-A1 METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. 2015-06-04 — — US disclosed
US-20150111839-A1 METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. 2015-04-23 — — US disclosed
EP-2595980-B1 METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES INC (US) 2014-09-03 — — EP disclosed
WO-2014042433-A2 COMPOUNDS AND COMPOSITIONS FOR MODULATING ADENOSINE A3 RECEPTOR ACTIVITY KAINOS MEDICINE, INC. (KR) 2014-03-20 — — WO disclosed
WO-2014035140-A2 COMPOUNDS AND COMPOSITIONS FOR MODULATING HISTONE METHYLTRANSFERASE ACTIVITY KAINOS MEDICINE, INC. (KR) 2014-03-06 — — WO disclosed
US-20120027752-A1 METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. (US) 2012-02-02 — — US disclosed
WO-2012012776-A1 METHODS AND COMPOUNDS FOR TREATING PARAMYXOVIRIDAE VIRUS INFECTIONS GILEAD SCIENCES, INC. (US) 2012-01-26 — — WO disclosed
Send feedback